US$ 26.89
fda warning bpc-157 human use not approved If worked as well as the internet says it does… …we'd probably have high quality trials by now. Instead we have... Lots of rat studies. Lots of podcasts. Lots of Is BPC-157 Banned? Oral vs.
Description
Brensocatib (AZD7986/INS1007) was identified as a highly potent, reversible, and selective inhibitor of human DPP1 and showed comparable effects on mouse, rat, dog, and rabbit DPP1

The barrel is narrower, so the 50 unit markings are more spread out than on a 1mL syringe

doi: 10.1126/science.274.5293.1704

Common adverse events include headache, dizziness, and injection site reactions